The clinical effects of the continuous intravenous and intra-arterial infusion of cancer chemotherapeutic compounds.
D061605:Administration, Intravenous; D000970:Antineoplastic Agents / Q000628:therapy*; D005493:Folic Acid Antagonists / Q000628:therapy*; D007261:Infusions, Intra-Arterial; D007263:Infusions, Parenteral; D009369:Neoplasms; D009705:Nucleosides / Q000628:therapy*; D009711:Nucleotides / Q000628:therapy*; D014498:Uracil / Q000031:analogs & derivatives
D000970:Antineoplastic Agents; D005493:Folic Acid Antagonists; D009705:Nucleosides; D009711:Nucleotides; D014498:Uracil
ANTINEOPLASTIC AGENTS/therapy; FOLIC ACID ANTAGONISTS/therapy; INFUSIONS, PARENTERAL; NUCLEOSIDES AND NUCLEOTIDES/therapy; URACIL/related compounds